Lucas Svetlana insider trades
Lucas Svetlana has filed 11 Form 4s with the SEC that we hold, for aTYR PHARMA INC (ATYR) (Director), Jasper Therapeutics, Inc. (JSPR) (Director) and Scribe Therapeutics, Inc. (SCTX) (Chief Business Officer). Across all of them we count 2 purchases worth $93.6K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($45.0K) and 0 sales ($0). The largest single trade was a purchase of 20,000 shares of Jasper Therapeutics, Inc. worth $48.6K, dated 2025-09-22. The first filing on our record is dated 2022-04-28 and the latest 2026-08-04.
aTYR PHARMA INC (ATYR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Jasper Therapeutics, Inc. (JSPR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-09-22 | P, purchase reported on Form 4 | 20,000 | $48.6K | 2025-09-24 |
Scribe Therapeutics, Inc. (SCTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-07-23 | P, purchase reported on Form 4 | 3,000 | $45.0K | 2026-07-27 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1781292) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms